HCC surveillance: Who is the target population?

Authors

  • Jordi Bruix M.D.,

    Corresponding author
    1. Barcelona Clínic Liver Cancer (BCLC) Group From the Liver Unit, Digestive Disease Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, Spain
    • BCLC Group, Liver Unit, Digestive Disease Institute, Hospital Clínic i Provincial, Villarroel 170, 08036-Barcelona, Catalonia, Spain; fax: (34) 93-2279803
    Search for more papers by this author
  • Josep M. Llovet M.D.

    1. Barcelona Clínic Liver Cancer (BCLC) Group From the Liver Unit, Digestive Disease Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, Spain
    Search for more papers by this author

No abstract is available for this article.

Ancillary